NCT00124176View on ClinicalTrials.gov

Continuous Levalbuterol for Treatment of Status Asthmaticus in Children

PHASE4CompletedINTERVENTIONAL
Enrollment

81

Participants

Timeline

Start Date

April 30, 2004

Primary Completion Date

February 28, 2006

Study Completion Date

February 28, 2006

Conditions
Asthma
Interventions
DRUG

Racemic albuterol (R+S albuterol)

20mg/hr continuous racemic albuterol

DRUG

Levalbuterol (R albuterol)

10mg/hr continuous nebulized levalbuterol

Trial Locations (1)

19104

The Children's Hospital of Philadelphia, Philadelphia

All Listed Sponsors
collaborator

Sumitomo Pharma America, Inc.

INDUSTRY

lead

Children's Hospital of Philadelphia

OTHER

NCT00124176 - Continuous Levalbuterol for Treatment of Status Asthmaticus in Children | Biotech Hunter | Biotech Hunter